135 related articles for article (PubMed ID: 24305528)
1. Estimating the early impact of the FDA safety communication on the use of surgical mesh.
Myers E; Geller E; Crane A; Robinson B; Matthews C
South Med J; 2013 Dec; 106(12):684-8. PubMed ID: 24305528
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of anterior elevate system for the treatment of anterior and apical pelvic floor descent: 2-year followup.
Rapp DE; King AB; Rowe B; Wolters JP
J Urol; 2014 Feb; 191(2):389-94. PubMed ID: 23973517
[TBL] [Abstract][Full Text] [Related]
3. Female pelvic medicine and reconstructive surgery practice patterns: IUGA member survey.
Ghoniem G; Hammett J
Int Urogynecol J; 2015 Oct; 26(10):1489-94. PubMed ID: 26017893
[TBL] [Abstract][Full Text] [Related]
4. Pelvic organ prolapse surgical management in Portugal and FDA safety communication have an impact on vaginal mesh.
Mascarenhas T; Mascarenhas-Saraiva M; Ricon-Ferraz A; Nogueira P; Lopes F; Freitas A
Int Urogynecol J; 2015 Jan; 26(1):113-22. PubMed ID: 25124092
[TBL] [Abstract][Full Text] [Related]
5. [Vaginal mesh operations in the urogynecological practice after the FDA warnings. Use or not to use mesh?].
Fekete Z; Körösi S; Németh G
Orv Hetil; 2018 Mar; 159(10):397-404. PubMed ID: 29504419
[TBL] [Abstract][Full Text] [Related]
6. Complications of vaginal mesh surgery.
Chermansky CJ; Winters JC
Curr Opin Urol; 2012 Jul; 22(4):287-91. PubMed ID: 22617058
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Providers Performing Urogynecologic Procedures on Medicare Patients 2012-2014.
Stone DE; Barenberg BJ; Pickett SD; OʼLeary DE; Quiroz LH
Female Pelvic Med Reconstr Surg; 2017; 23(2):75-79. PubMed ID: 28230614
[TBL] [Abstract][Full Text] [Related]
8. Variability in practice patterns in stress urinary incontinence and pelvic organ prolapse: results of an IUGA survey.
Kammerer-Doak D; Svabik K; Bazi T
Int Urogynecol J; 2017 May; 28(5):735-744. PubMed ID: 27752749
[TBL] [Abstract][Full Text] [Related]
9. FIGO review of statements on use of synthetic mesh for pelvic organ prolapse and stress urinary incontinence.
Ugianskiene A; Davila GW; Su TH;
Int J Gynaecol Obstet; 2019 Nov; 147(2):147-155. PubMed ID: 31353463
[TBL] [Abstract][Full Text] [Related]
10. Pelvic mesh complications in women before and after the 2011 FDA public health notification.
Rice NT; Hu Y; Slaughter JC; Ward RM
Female Pelvic Med Reconstr Surg; 2013; 19(6):333-8. PubMed ID: 24165446
[TBL] [Abstract][Full Text] [Related]
11. Mid term outcome of robotic mesh sacrocolpopexy.
Belsante M; Murray S; Dillon B; Zimmern P
Can J Urol; 2013 Feb; 20(1):6656-61. PubMed ID: 23433141
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 2011 FDA transvaginal mesh safety update on AUGS members' use of synthetic mesh and biologic grafts in pelvic reconstructive surgery.
Clemons JL; Weinstein M; Guess MK; Alperin M; Moalli P; Gregory WT; Lukacz ES; Sung VW; Chen BH; Bradley CS;
Female Pelvic Med Reconstr Surg; 2013; 19(4):191-8. PubMed ID: 23797515
[TBL] [Abstract][Full Text] [Related]
13. One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series.
Lo TS
J Minim Invasive Gynecol; 2010; 17(4):473-9. PubMed ID: 20547113
[TBL] [Abstract][Full Text] [Related]
14. Minimum 1.5-year results of "surgeon-tailored" transvaginal mesh repair for female stress urinary incontinence and pelvic organ prolapse.
Önol FF; Tosun F; Güzel R; Boylu U; Küçük EV; Gümüş E
Urology; 2012 Aug; 80(2):273-9. PubMed ID: 22857745
[TBL] [Abstract][Full Text] [Related]
15. [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence].
Hu CD; Chen YS; Yi XF; Ding JX; Feng WW; Yao LQ; Huang J; Zhang Y; Hu WG; Zhu ZL; Hua KQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):94-100. PubMed ID: 21426765
[TBL] [Abstract][Full Text] [Related]
16. Trends of Mesh Utilization for Stress Urinary Incontinence Before and After the 2011 Food and Drug Administration Notification Between FPMRS-Certified and Non-FPMRS-Certified Physicians: A Statewide All-Payer Database Analysis.
Siegal AR; Huang Z; Gross MD; Mehraban-Far S; Weissbart SJ; Kim JM
Urology; 2021 Apr; 150():151-157. PubMed ID: 32663554
[TBL] [Abstract][Full Text] [Related]
17. Use of vaginal mesh in the face of recent FDA warnings and litigation.
Mucowski SJ; Jurnalov C; Phelps JY
Am J Obstet Gynecol; 2010 Aug; 203(2):103.e1-4. PubMed ID: 20227672
[TBL] [Abstract][Full Text] [Related]
18. The scientific basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
Colaco M; Mettu J; Badlani G
BJU Int; 2015 Jun; 115(6):859-66. PubMed ID: 24889349
[TBL] [Abstract][Full Text] [Related]
19. Women's quality of life and sexual function after transvaginal anterior repair with mesh insertion.
El Haddad R; Svabik K; Masata J; Koleska T; Hubka P; Martan A
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):110-3. PubMed ID: 23265298
[TBL] [Abstract][Full Text] [Related]
20. Enmeshed in Controversy: Use of Vaginal Mesh in the Current Medicolegal Environment.
Kuhlmann-Capek MJ; Kilic GS; Shah AB; Diken ZM; Snyder RR; Phelps JY
Female Pelvic Med Reconstr Surg; 2015; 21(5):241-3. PubMed ID: 26313491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
